SUSMED,Inc. (TYO:4263)

Market Cap	10.47B
Revenue (ttm)	453.00M
Net Income (ttm)	-284.00M
Shares Out	16.81M
EPS (ttm)	-16.93
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	45,600
Average Volume	87,290
Open	613.00
Previous Close	623.00
Day's Range	613.00 - 622.00
52-Week Range	375.00 - 706.00
Beta	1.43
RSI	53.86
Earnings Date	Aug 8, 2025

About SUSMED,Inc.

SUSMED,Inc. develops and sells therapeutic applications in Japan. It develops smartphone based digital therapeutics applications for diseases with insomnia, breast cancer, and kidney disease. The company also develops and sells development platform for therapeutic apps and clinical trial systems. In addition, it offers medical data analysis and consulting services. The company was incorporated in 2015 and is headquartered in Tokyo, Japan.

• Industry: Medical - Healthcare Information Services
• Sector: Healthcare
• Founded: 2015
• Employees: 39
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4263

Financial Performance

In 2024, SUSMED,Inc.'s revenue was 342.00 million, a decrease of -35.47% compared to the previous year's 530.00 million. Losses were -357.00 million, 614.0% more than in 2023.